GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » EirGenix Inc (ROCO:6589) » Definitions » Deferred Policy Acquisition Costs

EirGenix (ROCO:6589) Deferred Policy Acquisition Costs


View and export this data going back to 2016. Start your Free Trial

What is EirGenix Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


EirGenix Business Description

Industry
Traded in Other Exchanges
N/A
Address
No. 101, Lane 169, Kangning Street, Xizhi District, New Taipei, TWN, 22180
EirGenix Inc is engaged in the research and development of biosimilars and new drugs, as well as biopharmaceutical contract development and manufacturing services, which included cell line construction platforms, process development platforms, analytical science and protein identification. Furthermore, the company has two PIC/S GMP facilities, one for mammalian cells and one for microbial, to provide clinical trial drug and commercial drug production. Its products include CRM197 CARRIER PROTEIN, PRODUCT PIPELINE, COVID-19 ANTIGEN RAPID TEST.